Precision Business Insights
Portfolio

 

Acute Lymphoblastic Leukemia Pipeline Drugs Geographic Focus

ImageReport NamePrice
Acute Lymphoblastic Leukemia Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018$ 2,000.00$ 6,000.0036200000